BioMarin to Participate in Two Investor Conferences in October

SAN RAFAEL, Calif., Sept. 19, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in two investor conferences this October. To access the events that are accessible by live webcasts, please visit the investor section of the BioMarin website, A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit Information on BioMarin's website is not incorporated by reference into this press release.



             Traci McCarty                
         Debra Charlesworth

                BioMarin Pharmaceutical Inc.         BioMarin Pharmaceutical Inc.

             (415) 455-7558               
         (415) 455-7451


View original content to download multimedia:

SOURCE BioMarin Pharmaceutical Inc.

Company Codes: NASDAQ-NMS:BMRN

Back to news